MOSCOW (MRC) -- Essen-based Evonik Industries, a leading specialty chemicals manufacturer, has recently inaugurated a new silanes competence centre at its Rheinfelden, Germany, as per GV.
The company has invested a low two-digit million Euro amount in the 3,500 m2 laboratory building, where approximately 100 employees will be working.
Besides research and development, the competence centre will also be home to the applied technology, analytics, and quality management departments. Silane research has been carried out at this site for more than 80 years - the first patent for a silane was granted here in 1934, says the company.
Evonik produces silanes at sites in Germany, Belgium, China, and the USA. The portfolio includes a wide range of chlorosilanes as well as organo-functional and sulphur-functional silanes.
As MRC informed previously, Evonik Industries invested over EUR400 mln in its plants in Germany in 2015. Last year, Evonik once again demonstrated its considerable power to create at its German sites. Thus, according to a recent projection, the company invested more than EUR 400 million in its domestic production plants. The lion’s share of the funds (around two-thirds) was divided among Evonik’s five-largest sites in Germany: Marl (hundreds of millions of euros), Hanau, Essen, Darmstadt, and Wesseling (tens of millions of euros at each site).
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world.
MRC